| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/10/2001 | CA2389335A1 Gene expression directed by a super-psa promoter |
| 05/10/2001 | CA2389312A1 Heterocyclic cytotoxic agents |
| 05/10/2001 | CA2389293A1 Method for administering a phosphodiesterase 4 inhibitor |
| 05/10/2001 | CA2389259A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists |
| 05/10/2001 | CA2389234A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists |
| 05/10/2001 | CA2389229A1 Compounds having mif antagonist activity |
| 05/10/2001 | CA2389226A1 1,4 substituted piperidinyl nmda/nr2b antagonists |
| 05/10/2001 | CA2388333A1 Method and compositions for treating pulmonary diseases |
| 05/10/2001 | CA2388308A1 Gpcr-kd5 polypeptides and dna sequences thereof |
| 05/10/2001 | CA2388202A1 Polymorphic form of a tachykinin receptor antagonist |
| 05/10/2001 | CA2388159A1 Osmotic controlled release drug delivery device |
| 05/10/2001 | CA2387808A1 Human chemokine beta-13 |
| 05/10/2001 | CA2387801A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | CA2387745A1 Positive modulators of nicotinic receptor agonists |
| 05/10/2001 | CA2387741A1 Positive modulators of nicotinic receptor agonists |
| 05/10/2001 | CA2387136A1 26 human secreted proteins |
| 05/10/2001 | CA2386938A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 05/10/2001 | CA2386641A1 32 human secreted proteins |
| 05/10/2001 | CA2385665A1 Modulation of enos activity and therapeutic uses thereof |
| 05/10/2001 | CA2358921A1 Oxetanone derivatives |
| 05/10/2001 | CA2324800A1 Use of apo b secretion/mtp inhibitors |
| 05/09/2001 | EP1097994A2 Human bad polypeptides, encoding nucleic acids and methods of use |
| 05/09/2001 | EP1097989A2 Ndr phosphokinase |
| 05/09/2001 | EP1097942A2 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes |
| 05/09/2001 | EP1097921A1 Phenylhydrazines |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097713A1 Inhibitors of the inositol polyphosphate 5-phosphatase ship-2 molecule |
| 05/09/2001 | EP1097711A2 Treatment of pulmonary hypertension |
| 05/09/2001 | EP1097710A2 Combination product for treating niddm |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097382A2 Imidazoline receptor binding compounds |
| 05/09/2001 | EP1097241A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 05/09/2001 | EP1097210A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 05/09/2001 | EP1097203A1 Human presenilin-associated protein |
| 05/09/2001 | EP1097202A2 Human transport protein homologs |
| 05/09/2001 | EP1097201A1 Snurpotine i human m 3?g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 05/09/2001 | EP1097200A1 Pharmaceutical uses of nab1 and nab2 |
| 05/09/2001 | EP1097193A1 Liver stem cell |
| 05/09/2001 | EP1097168A2 Compounds and methods for modulating cadherin-mediated functions |
| 05/09/2001 | EP1097167A2 Neurotrophic growth factor |
| 05/09/2001 | EP1097165A1 Novel inhibitors of angiogenesis and tumor growth |
| 05/09/2001 | EP1097159A1 Phosphinous and phosphonic acid derivatives used as medicaments |
| 05/09/2001 | EP1097149A1 Bicyclohexane derivatives |
| 05/09/2001 | EP1097145A1 Polyhydroalkylpyrazine derivatives and their preparation and medicines containing them |
| 05/09/2001 | EP1097141A1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent |
| 05/09/2001 | EP1097138A1 Pharmaceutical compositions comprising 2-quinolones |
| 05/09/2001 | EP1097137A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| 05/09/2001 | EP1097129A1 N-benzocycloalkyl-amide derivatives and their use as medicaments |
| 05/09/2001 | EP1097127A1 Diacylhydrazine derivatives as integrin inhibitors |
| 05/09/2001 | EP1096949A2 Treatment of celiac disease with interleukin-15 antagonists |
| 05/09/2001 | EP1096941A1 Bone marrow cells as a source of neurons for brain and spinal cord repair |
| 05/09/2001 | EP1096938A1 Anti-irritant compositions containing a cyclic 2'-deoxy-nucleotide |
| 05/09/2001 | EP1096933A1 Use of an inhibitor of cytochrome p450 optionally combined with an antifungal agent for treating mycoses |
| 05/09/2001 | EP1096932A2 Antihypertensive combination of valsartan and calcium channel blocker |
| 05/09/2001 | EP1096930A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 05/09/2001 | EP1096929A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 05/09/2001 | EP1096927A1 Composition for treatment of stress |
| 05/09/2001 | EP0633776B1 Compounds useful for treating allergic and inflammatory diseases |
| 05/09/2001 | EP0450040B1 Pharmaceutical and cosmetic depigmentation compositions with a caffeic acid base |
| 05/09/2001 | CN1294595A Hydrophobically-modified protein compsns, and methods |
| 05/09/2001 | CN1294590A Method of 3-substituted adenines via 2-thioxanthines |
| 05/09/2001 | CN1294581A Pyridine derivative and pharmaceutical contg. same |
| 05/09/2001 | CN1294579A Sulfonamide-contg. indole compounds |
| 05/09/2001 | CN1294522A Appts. and processes for whole-body hyperthermia |
| 05/09/2001 | CN1294516A Antitumor compsn. contg. synergistic compsn. of anthracycline derivative with camptothecin derivate |
| 05/09/2001 | CN1293985A Process for preparing health-care oral liquid for human biologic clock |
| 05/09/2001 | CN1065535C Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 05/09/2001 | CN1065531C Aminotetrazole derivatives useful as nitric oxide synthase inhibotors |
| 05/09/2001 | CN1065438C Cyclic adhesion inhibitors |
| 05/09/2001 | CN1065436C Mfg. process for health buthus martensi liquor |
| 05/09/2001 | CN1065433C Oily prepn. and method of prodn. thereof |
| 05/09/2001 | CN1065428C Matrix type patch preparations |
| 05/08/2001 | US6229029 11β-aryl substituted 14,17-ethanoestratriens, method for the production of these compounds and their use in the production of medicaments |
| 05/08/2001 | US6229025 Process for alkylating hindered sulfonamides |
| 05/08/2001 | US6229016 Method for treating tumors using 2-aryl-naphthyridin-4-ones |
| 05/08/2001 | US6228991 Amino acid sequence; diagnosis, treatment or prevention of reproductive, developmental, neoplastic, and immunological/ autoimmune disorders; anticarcinogenic agents; antitumor/antiarthrtic/antidiabetic agents; endometriosis |
| 05/08/2001 | US6228987 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 05/08/2001 | US6228982 Stable compounds that form double-stranded, helical structures mimicking double-stranded dna; diagnosis; prophylaxis; therapy; antisense agents |
| 05/08/2001 | US6228893 Treating dementia |
| 05/08/2001 | US6228890 Use of alicyclic diamines as immunomodulators |
| 05/08/2001 | US6228889 Methods for treatment of conditions associated with lactosylceramide |
| 05/08/2001 | US6228888 Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors |
| 05/08/2001 | US6228872 Neurotrophic diamide and carbamate agents |
| 05/08/2001 | US6228859 Antiasthmatic, antiinflammatory, antiallergen and antidepressant agents |
| 05/08/2001 | US6228858 2,5-methylol-3,6-(aminomethyl)-hydroquinone; diabetes nephropathy; controlling blood sugar |
| 05/08/2001 | US6228855 Topoisomerase inhibitors; antitumor agents |
| 05/08/2001 | US6228853 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/08/2001 | US6228847 Inhibitors of nucleoside metabolism |
| 05/08/2001 | US6228837 Endothelial monocyte activating polypeptide II: a mediator which activates host response |
| 05/08/2001 | US6228834 Treating gramnegative bacterial infections; neutralizing lipopolysaccharides |
| 05/08/2001 | US6228617 Nucleotide sequence coding a trigger chaperone protein; for use in screening bactericides |
| 05/08/2001 | US6228614 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| 05/08/2001 | US6228584 Nucleotide sequences for use in the detection of streptococcus |
| 05/08/2001 | US6228398 Dosage form for increasing patient compliance by reducing dosage frequency; attention deficit disorder, methylphenidate or salts |
| 05/08/2001 | US6228387 Integrated comprehensive hemorrhoid treatment compositions and regimen |
| 05/08/2001 | US6228380 Delivery of hydroxy carboxylic acids |
| 05/08/2001 | US6228364 Isolation of polypeptides with sequences |
| 05/08/2001 | US6228363 Peptides for the treatment of systemic lupus erythematosus |